FutureWorld (OTCMKTS:FWDG) and Savara (NASDAQ:SVRA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, valuation, risk, analyst recommendations and earnings.
This is a breakdown of current recommendations and price targets for FutureWorld and Savara, as provided by MarketBeat.
Savara has a consensus target price of $24.75, indicating a potential upside of 218.94%. Given Savara’s higher possible upside, analysts clearly believe Savara is more favorable than FutureWorld.
This table compares FutureWorld and Savara’s gross revenue, earnings per share and valuation.
FutureWorld has higher earnings, but lower revenue than Savara.
This table compares FutureWorld and Savara’s net margins, return on equity and return on assets.
Insider Institutional Ownership
51.1% of Savara shares are held by institutional investors. 6.1% of Savara shares are held by insiders. Strong institutional